HYPERAMMONEMIA

 

HYPERAMMONEMIA

 

DEFINITION:

A heterogeneous group of disorders characterized by elevated ammonia in the blood resulting in altered levels of consciousness and/or persistent vomiting.

EPIDEMIOLOGY:

  • incidence: rare
  • age of onset:
    • newborn -> childhood
  • risk factors:
    • see below

DIFFERENTIAL DIAGNOSIS:

1. Primary

1. Urea Cycle Defects

  • Carbamoyl Phosphate Synthethase (CPS) Deficiency
  • Ornithine Transcarbamylase (OTC) Deficiency
  • Citrullinemia
  • Argininosuccinic Aciduria
  • Argininemia

2. Transient Hyperammonemia of the Newborn

2. Secondary

1. Organic Acidopathies

  • Methylmalonic Acidemia
  • Propionic Acidemia
  • Isovaleric Acidemia

2. Fatty Acid Oxidation Defects

  • MCAD, LCAD, SCAD

3. Reye's Syndrome

PATHOGENESIS:

1. Background

  • catabolism of nitrogenous compounds (endogenous and exogenous proteins) produces amino acids which are further metabolized to ammonia
  • as ammonia is toxic to cells, the liver is the primary organ for maintaining plasma ammonia levels <40 uM
  • the liver eliminates ammonia by 2 routes:
    • conversion of glutamate to glutamine
    • conversion of ammonia to urea via the urea cycle
  • assessment of hyperammonemia due to a urea cycle defect (hyperammonemia + normal anion gap), begins with the assessment of the 3rd enzyme in the urea cycle (argininosuccinate synthe-tase); a defect in this enzyme will result in an elevation of citrulline
  • this initial assessment is followed by an assessment of the 4th and 5th enzymes of the urea cycle (argininosuccinate lyase, arginase); a defect in these enzymes will result in a moderate elevation of citrulline
  • an assessment of the 1st and 2nd enzymes of the urea cycle (carbamoyl phosphate synthetase, ornithine transcarbamylase) is last; a defect in these enzymes will result normal or low citrulline levels

CLINICAL FEATURES:

1. Metabolic Manifestations

1. Newborn

  • usually normal at birth with onset of features 24-72 hours after feeding (protein load) commences:

1. Neurological Manifestations

  • lethargy -> coma
  • infantile hypotonia
  • neonatal seizures

2. Gastrointestinal Manifestations

  • persistent vomiting (+/- dehydration)
  • poor feeding
  • hepatomegaly

3. Others

  • hyperventilation (due to a respiratory alkalosis)
  • hypothermia

2. Childhood

  • usually present after a sudden protein load or an inter-current infection with recurrent episodes of:

1. Neurological Manifestations

  • lethargy -> coma
  • acute ataxia
  • hyperactivity

2. Gastrointestinal Manifestations

  • persistent vomiting (+/- dehydration)
  • hepatomegaly

INVESTIGATIONS:

1. Serum

  • venous hyperammonemia (normal <40 uM)
    • primary (>500 uM); secondary (<200 uM)
  • blood gas, electrolytes

1. If anion gap wide:

  • check urine for organic acids (Organic Acidopathies, Fatty Acid Oxidation Defects)

2. If anion gap normal:

  • check plasma amino acids for
  • 1. Citrulline
    • if >1000 uM (Citrullinemia)
    • if 100-300 uM
    • elevated argininosuccinic acid (Argininosuccinic Aciduria)
    • elevated arginine (Argininemia)
    • if 0 - trace
    • elevated orotic acid (OTC Deficiency)
    • low orotic acid (CPS Deficiency)

2. Urine

  • orotic acid

     

Note: The primary defects will generally have higher serum ammonia levels and have a normal anion gap metabolic acidosis.

MANAGEMENT (Urea Cycle Defects):

1. Supportive

  • chronic diseases with a life-long risk of episodes of hyperammonemia and thus must:
    • provide long-term follow-up
    • moniter ammonia levels
    • coordinate a multidisciplinary approach:
      • Paediatrics, Neurology, Dietary, Genetics, Metabolics
    • plan for acute episodes

2. Goals of Therapy

  • symptomatic control of and avoidance of acute episodes
  • not curative

3. Diet

1. Protein Restriction

1. Exogenous

  • IV D10W (during an acute episode)
  • Mead Johnson 80056 Formula
    • non-protein containing formula
    • supplement with citrulline or arginine

2. Endogenous

  • High Caloric Diet
    • use to avoid or during an acute episode to minimize tissue catabolism and thus the breakdown of endogenous protein

4. Convert Nitrogen to an Excretable Compound

1. Sodium Benzoate

  • conjugates with glycine and excreted as hippuric acid

2. Sodium Phenylacetate

  • conjugates with glutamine and excreted as phenylacetyl-glutamine

3. Dialysis

  • Peritoneal or Hemodialysis

5. Prognosis

  • 100% mortality if untreated
  • there is a direct correlation between the duration of hyper-ammonemic coma and morbidity (mental retardation, developmental delays, cortical atrophy)
  • good prognosis if disorder is treated prospectively from birth

 

 

 

Pediatric Database - HYPERAMMONEMIA

Pediatric Organization - Pedbase [at] Gmail.com